- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196402
Narrow Band Imaging in the Prediction of Surveillance Intervals After Polypectomy in Community Practice: Ready for (a European) Prime Time
Several reports have suggested that an endoscopic diagnosis of adenoma, by means of narrow band imaging (NBI), might allow the determination of polyp management and surveillance interval, particularly in patients with diminutive polyps (< 5mm), in which the advanced histological features are uncommon and the prevalence of invasive cancer is negligible (1). On this basis, the American Society of Gastrointestinal Endoscopy (ASGE) has set an initiative evaluating the applicability of real-time endoscopic polyp assessment in clinical practice (1), which states that:
- for diminutive polyps to be resected and discarded without pathologic assessment, endoscopic technology (when used with high confidence) used to determine histology of polyps < 5mm in size, when combined with the histopathologic assessment of polyps >5 mm in size, should provide a > 90% agreement in assignment of post-polypectomy surveillance intervals when compared to decisions based on pathology assessment of all identified polyps.
- In order for a technology to be used to guide the decision to leave suspected rectosigmoid hyperplastic polyps <5 mm in size in place (without resection), the technology should provide > 90% negative predictive value (when used with high confidence) for adenomatous histology
This strategy could potentially exert a significant impact on colonoscopy practice, by decreasing at some extent pathology-associated costs, although those related to histological analysis of >5mm polyps is maintained.
In a recent study performed in our Centre (2), we restricted the application of the resect and discard strategy to patients with small or diminutive polyps only, achieving an accordance between endoscopy-directed and histology-directed surveillance strategy of about 85% in both populations. This approach, where decisions on patient management are driven only by the "in vivo" endoscopic assessment, provides on one hand a slightly lower accordance than the threshold of 90% set by the PIVI, but on the other one it allows the complete spare of pathology related costs, although for a smaller proportion of patients. Moreover we observed a negative predictive value of 86% for the presence of adenoma within the diminutive polyps cohort, although a separate analysis for left sided ones was not performed.
AIms of this single center, prospective, observational study:
- To prospectively evaluate the accordance between the endoscopy-directed and histology-directed surveillance strategies by applying the resect and discard strategy for diminutive polyps according to the PIVI statements
- To assess the economic impact of the resect and discard strategy when applied either according to the PIVI statements or to restrictedly to subjects with diminutive polyps only
- To provide a temporary validation of diagnostic performances of the resect and discard strategy for our group and the potential presence of a learning effect for the methodology
- Accordance between endoscopists' and nurses' categorization of adenomas according to standardized criteria (see below)
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Como, Italy, 22100
- Ospedale Valduce
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance).
Exclusion criteria:
- patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
- patients with inadequate bowel preparation
- patients in which cecal intubation was not achieved or scheduled for partial examinations
- polyps could not be resected due to ongoing anticoagulation or could not be retrieved for pathologic assessment
Description
Inclusion Criteria:
- Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance).
Exclusion criteria:
- patients with CRC history or hereditary polyposis syndromes or hereditary non-polyposis colorectal cancer
- patients with inadequate bowel preparation
- patients in which cecal intubation was not achieved or scheduled for partial examinations
- polyps could not be resected due to ongoing anticoagulation or could not be retrieved for pathologic assessment
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
study population
Consecutive adult (18-80 yrs) outpatients undergoing colonoscopy for routine indications (screening, symptoms, surveillance). Exclusion criteria:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
proportion of cases in which the accordance between the endoscopy-directed and histology-directed surveillance strategies by applying the resect and discard strategy for diminutive polyps according to the PIVI statements was observed
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 5/2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resect and Discard Strategies for Colonoscopy
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedSedation and Anesthesia for Adult Colonoscopy ProceduresChina
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedBowel Preparation for ColonoscopyMexico
-
Zhaoshen LiCompletedSensitivity of the ADS in Identifying Polyps in Real-world Colonoscopy | Mean Number of Polyps Per Colonoscopy for Colonoscopists and Colonoscopists + ADSChina